Search Results

The default setting for search results displays All Content. If you prefer to see recent content only, please adjust the date filter.

268 Results Found

AHA files brief defending Tennessee’s 340B contract pharmacy law

The AHA June 4 filed an amicus brief (https://www.aha.org/amicus-brief/2025-06-04-aha-files-brief-defending-tennessees-340b-contract-pharmacy-law) in the U.S. District Court for the Middle District of Tennessee in defense of the state’s 340B contract pharmacy law prohibiting drug companies from denying hospitals the same 340B discounts for drugs dispensed at community pharmacies that would be provided via in-house pharmacies.

GAO says CMS should target behavioral health services in prior authorization audits

The Government Accountability Office May 29 released a report recommending the Centers for Medicare & Medicaid Services target behavioral health services when auditing Medicare Advantage plans’ use of prior authorization.

AHA podcast: Bringing Virtual Behavioral Health Care Access to Rural Youth in West Virginia

Adrienne Coopey, D.O., a child and adolescent psychiatrist at the West Virginia University Rockefeller Neuroscience Institute, discusses how a fully virtual collaborative care model helps deliver early behavioral health interventions and improve access and outcomes for children across West Virginia

CMS to expand audits of MA plans

The Centers for Medicare & Medicaid Services May 21 announced it will immediately begin annual audits of all Medicare Advantage plans and work to clear a backlog of audits from 2018 through 2024.

Judge: HHS has authority to preapprove implementation of 340B ‘rebate models’

A U.S. district court judge for the District of Columbia May 15 ruled the Department of Health and Human Services must preapprove the use of 340B “rebate models” before they can be implemented, which the department has not yet done for any of the models pursued by the plaintiff drug companies. 

AHA files brief defending South Dakota’s 340B contract pharmacy law

The AHA May 14 filed an amicus brief in the U.S. District Court for the District of South Dakota in defense of the state’s 340B contract pharmacy law prohibiting drug companies from denying hospitals the same 340B discounts for drugs dispensed at community pharmacies that would be provided via in-house pharmacies.

CMS releases draft guidance for third cycle of Medicare drug price negotiations

The Centers for Medicare & Medicaid Services May 12 released

House Ways and Means Committee advances its portion of FY 2025 reconciliation bill 

The House Ways and Means Committee today advanced its portion of the fiscal year 2025 reconciliation bill by a 26-19 vote along party lines, following an hours-long, overnight markup.

AHA comments to HHS on 340B drug rebate models

The AHA May 9 urged the Department of Health and Human Services to deny drug companies’ requests to approve their unlawful 340B rebate models.

AHA shares concerns on data exchange provision under drug price negotiation program

The AHA May 1 expressed concerns to the Centers for Medicare & Medicaid Services about the payment process established under the Medicare Drug Price Negotiation Program, explaining ways it undermines the purpose of the 340B Drug Pricing Program.